Online Broadcast: Ural Neuro-Urology Symposium in Yekaterinburg (Russia)

Apr 22, 2021We are glad to announce that on April 22nd 2021 14:30 (local time: GMT+5)) the 4th Ural Neuro-Urology Symposium will take place. Although also this year's symposium will take place offline/face-to-face, this meeting will be broadcasted online and all INUS members are invited to join the meeting for free.
read more

read more

INUS Webinar for Junior Members

Feb 25, 2021Dear INUS members,
We are happy to share with you the recording of a highly intersting and well attended INUS Webinar on neuro-urology held on February 20th 2021.
read more

read more

INUS congratulates...

Feb 9, 2021Congratulations to Prof. Dr. Kadir Onem, chairman of the Turkish INUS chapter, to the prestigious "ICS Best Presentation Award" at the ICS 2020 online congress for this video presentation of his abstract on "Catheterizable Continent Cutaneous Diversion with Extended Spiral Monti (ONEM)".
read more

read more

REGISTER NOW: INUS Webinar for Junior Members (and interested non-junior members)

Feb 20, 2021On February 20th 2021 at 10:00 CET | 16:00 MET a webinar specially designed for our young colleagues dealing with neuro-urology will take place. Free registration is open from now on: https://bit.ly/2O2Lc6z [...]
read more

read more

TOPICS IN NEURO-UROLOGY: What is the future of Sacral Anterior Root Stimulation (SARS)?

Oct 16, 2020SARS has been used in over 20 countries to restore bladder emptying after spinal cord injury, and its effectiveness and cost-effectiveness are well documented, but it is still not commonly used. What are the reasons for this?
read more

read more

CONTROVERSY IN NEURO-UROLOGY: Is there any relationship between Covid-19 and Lower Urinary Tract Symptoms (LUTS)?

Aug 3, 2020Have you experience with patients that started with LUTS with or after Covid-19 positive results? Please be so kind to fill in this short survey. Many thanks in advance!
read more

read more

SAARC Webinar on Overactive Bladder

Aug 27, 2020INUS is happy to be part of the SAARC Webinar on Overactive Bladder taking place TODAY, August 27th, at 18:00-21:00 Indian Standard Time (14:30-17:30 MET).
To join, register now!
read more

read more

PAPER OF THE MONTH: Reasons for cessation of clean intermittent catheterization after spinal cord injury: Results from the Neurogenic Bladder Research Group spinal cord injury registry

Aug 13, 2020With comment by Mario Averbeck:
The NBRG registry is a prospective observational study examining neurogenic‐bladder related QoL among individuals after SCI. Participants were recruited throughout the United States and Canada, answering telephonic interviews and electronic questionnaires. Progressive and congenital neurologic disorders were exclusion criteria.[...]
read more

read more

PAPER OF THE MONTH: Urological presentations of adult primary tethered cord syndrome

Jul 7, 2020With comment by Howard Goldman:
All of us are familiar with patients who have neurourological manifestations of tethered cord syndrome related to congenital spinal dyraphism. Far less common are symptoms related to tethered cord that present in adults previously unknown to have any spinal anomaly. [...]
read more

read more

INUS Annual Congress 2022

Jun 30, 2020Do you want to become the local organizer of the INUS Annual Congress 2022? We are looking forward to your application by July 31st.
read more

read more

PAPER OF THE MONTH: Anti-Nogo-A Antibodies As a Potential Causal Therapy for Lower Urinary Tract Dysfunction after Spinal Cord Injury

May 1, 2020With comment by Naoki Yoshimura:
Chronic spinal cord injury (SCI) induces lower urinary tract dysfunction (LUTD) such as detrusor overactivity and detrusor sphincter dyssynergia (DSD), potentially leading to life-threatening consequence. This study [...]
read more

read more

PAPER OF THE MONTH: MicroRNAs as potential biomarkers to predict the risk of urinary retention following intradetrusor onabotulinumtoxin‐A injection

May 1, 2020With comment by Naoki Yoshimura:
Intradetrusor injection of onabotulinumtoxin‐A (onaBoNT‐A) has been used for the treatment of refractory OAB, but sometimes results in high post-void residual urine volume (PVR) after the treatment. This study [...]
read more

read more

LogIn

Please enter your email and password to login.